Analyst firms · Morgan Stanley · CAH

Morgan Stanley CAH price target and rating history

Cardinal Health Inc. (CAH) · Health Care

Morgan Stanley rates Cardinal Health Inc. (CAH) Overweight with a $76 price target, as of its latest action on Aug 22, 2022. It has published 3 rating actions on CAH since December 2021, including 1 upgrade and 0 downgrades.

Current rating
Overweight
Price target
$76
Median target, all firms
Too few
Actions on CAH
3

Morgan Stanley price target on CAH

$76$65$5420222023202420252026
Morgan Stanley price target on CAH, each point a stated target, December 2021 to August 2022.

Every Morgan Stanley rating on CAH

How other firms rate CAH

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsOutperform$276Aug 19, 2026
William BlairOutperformApr 28, 2026
CitigroupBuyJan 9, 2026
BarclaysOverweight$243Dec 9, 2025

Questions about Morgan Stanley and CAH

What is Morgan Stanley's price target for CAH?
Morgan Stanley's latest stated price target for Cardinal Health Inc. (CAH) is $76, from its action on Aug 22, 2022.
What is Morgan Stanley's rating on CAH?
Morgan Stanley rates CAH Overweight, a bullish rating, as of Aug 22, 2022.
When did Morgan Stanley last change its view on CAH?
On Aug 22, 2022, Morgan Stanley resumes coverage at Overweight, price target $70 to $76.

More CAH rating histories

All Morgan Stanley ratingsCAH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.